Idexx Laboratories (IDXX) Other Non-Current Liabilities (2009 - 2026)

Idexx Laboratories has reported Other Non-Current Liabilities for 18 years, with the latest figure at $56.5 million in Q2 2026.

• On a quarterly basis, Other Non-Current Liabilities fell 0.5% year-over-year to $56.5 million in Q2 2026; TTM through Jun 2026 was $56.5 million, a 0.5% decrease from a year earlier, with the FY2025 full-year figure at $56.5 million, up 27.48% from the prior year.
• Other Non-Current Liabilities was $56.5 million for Q2 2026 at Idexx Laboratories, up from $54.0 million in the prior quarter.
• The five-year high for Other Non-Current Liabilities was $71.8 million in Q1 2022, with the low at $44.3 million in Q4 2024.
• Average Other Non-Current Liabilities over 5 years is $61.0 million, with a median of $61.5 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Other Non-Current Liabilities sank 32.33% in 2024, then climbed 27.48% in 2025.
• Over 5 years, Other Non-Current Liabilities stood at $67.6 million in 2022, then declined by 3.05% to $65.5 million in 2023, then tumbled by 32.33% to $44.3 million in 2024, then gained by 27.48% to $56.5 million in 2025, then fell by 0.04% to $56.5 million in 2026.
• The last three Other Non-Current Liabilities figures came in at $56.5 million (Q2 2026), $54.0 million (Q1 2026), and $56.5 million (Q4 2025), per Business Quant data.